Black Rock Inc. Vista Gen Therapeutics, Inc. Transaction History

Black Rock Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.12 - $0.3 $112,138 - $280,345	934,486 Added 7.62%	13,202,454 $1.58 Million
Q4 2022 Feb 13, 2023	BUY	$0.09 - $0.16 $51,607 - $91,745	573,412 Added 4.9%	12,267,968 $1.23 Million
Q3 2022 Nov 14, 2022	SELL	$0.14 - $1.07 $3,007 - $22,986	-21,483 Reduced 0.18%	11,694,556 $1.78 Million
Q2 2022 Aug 12, 2022	SELL	$0.88 - $1.73 $14,418 - $28,346	-16,385 Reduced 0.14%	11,716,039 $10.3 Million
Q1 2022 May 12, 2022	SELL	$1.14 - $2.09 $184,416 - $338,097	-161,769 Reduced 1.36%	11,732,424 $14.5 Million

Q4 2021 Feb 10, 2022	BUY	$1.67 - $2.76 $243,354 - $402,189	145,721 Added 1.24%	11,894,193 $23.2 Million
Q3 2021 Nov 09, 2021	BUY	$2.62 - $3.45 $257,949 - $339,666	98,454 Added 0.85%	11,748,472 $32.2 Million
Q2 2021 Aug 11, 2021	BUY	$1.96 - $3.15 $22.8 Million - $36.7 Million	11,650,018 New	11,650,018 $36.7 Million

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $720M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.